Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
11
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Race Geoffrey | Director | 8 | $0 | $0 | 2023-03-08 |
| Benz Edward JR | Director | 8 | $0 | $0 | 2023-03-08 |
| Forster Eliot | President and CEO | 15 | $0 | $0 | 2023-03-08 |
| Kayitalire Louis | Chief Medical Officer | 17 | $0 | $9.8K | 2023-03-08 |
| Brewis Neil | Chief Scientific Officer | 15 | $0 | $0 | 2023-03-08 |
| Klein Pamela M. | Director | 6 | $0 | $0 | 2023-03-08 |
| Brady Todd C | Director | 11 | $0 | $0 | 2023-03-08 |
| Bermingham Nessan | Director | 11 | $0 | $0 | 2023-03-08 |
| Arkowitz David | Director | 12 | $0 | $0 | 2023-03-08 |
| DEPTULA-HICKS DARLENE M | Treasurer and CFO | 13 | $0 | $0 | 2023-03-08 |
| Krol Patrick Johan Hendrik | Director | 1 | $0 | $0 | 2021-06-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Arkowitz David | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Arkowitz David | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Benz Edward JR | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Benz Edward JR | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 3,937 | — | $0 | 0 | SEC↗ |
| Benz Edward JR | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Bermingham Nessan | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Bermingham Nessan | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Bermingham Nessan | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 34,111 | — | $0 | 0 | SEC↗ |
| Race Geoffrey | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Race Geoffrey | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Brewis Neil | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2023-03-08 | 2023-03-09 | 132,469 | — | $0 | 0 | SEC↗ |
| Brewis Neil | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2023-03-08 | 2023-03-09 | 74,263 | — | $0 | 0 | SEC↗ |
| Brewis Neil | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2023-03-08 | 2023-03-09 | 22,561 | — | $0 | 0 | SEC↗ |
| Brady Todd C | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Brady Todd C | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| DEPTULA-HICKS DARLENE M | See Remarks | D To issuer deriv | 2023-03-08 | 2023-03-09 | 59,823 | — | $0 | 0 | SEC↗ |
| DEPTULA-HICKS DARLENE M | See Remarks | D To issuer deriv | 2023-03-08 | 2023-03-09 | 24,902 | — | $0 | 0 | SEC↗ |
| DEPTULA-HICKS DARLENE M | See Remarks | D To issuer deriv | 2023-03-08 | 2023-03-09 | 25,894 | — | $0 | 0 | SEC↗ |
| DEPTULA-HICKS DARLENE M | See Remarks | D To issuer deriv | 2023-03-08 | 2023-03-09 | 28,426 | — | $0 | 0 | SEC↗ |
| Klein Pamela M. | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Klein Pamela M. | Director | D To issuer deriv | 2023-03-08 | 2023-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| Forster Eliot | PRESIDENT AND CEO | D To issuer deriv | 2023-03-08 | 2023-03-09 | 126,909 | — | $0 | 0 | SEC↗ |
| Forster Eliot | PRESIDENT AND CEO | D To issuer deriv | 2023-03-08 | 2023-03-09 | 165,028 | — | $0 | 0 | SEC↗ |
| Forster Eliot | PRESIDENT AND CEO | D To issuer deriv | 2023-03-08 | 2023-03-09 | 127,924 | — | $0 | 0 | SEC↗ |
| Kayitalire Louis | CHIEF MEDICAL OFFICER | D To issuer deriv | 2023-03-08 | 2023-03-09 | 35,719 | — | $0 | 0 | SEC↗ |
| Kayitalire Louis | CHIEF MEDICAL OFFICER | D To issuer deriv | 2023-03-08 | 2023-03-09 | 27,289 | — | $0 | 0 | SEC↗ |
| Kayitalire Louis | CHIEF MEDICAL OFFICER | D To issuer deriv | 2023-03-08 | 2023-03-09 | 53,634 | — | $0 | 0 | SEC↗ |
| Kayitalire Louis | CHIEF MEDICAL OFFICER | D To issuer deriv | 2023-03-08 | 2023-03-09 | 12,880 | — | $0 | 0 | SEC↗ |
| Arkowitz David | Director | U Tender | 2023-03-08 | 2023-03-09 | 8,386 | $7.12 | $59.7K | 0 | SEC↗ |
| Benz Edward JR | Director | D To issuer | 2023-03-08 | 2023-03-09 | 4,385 | $7.12 | $31.2K | 0 | SEC↗ |
| Bermingham Nessan | Director | D To issuer | 2023-03-08 | 2023-03-09 | 6,328 | $7.12 | $45.1K | 0 | SEC↗ |
| Bermingham Nessan | Director | U Tender | 2023-03-08 | 2023-03-09 | 97,547 | $7.12 | $694.5K | 6,328 | SEC↗ |
| Race Geoffrey | Director | U Tender | 2023-03-08 | 2023-03-09 | 3,937 | $7.12 | $28.0K | 0 | SEC↗ |
| Brewis Neil | CHIEF SCIENTIFIC OFFICER | D To issuer | 2023-03-08 | 2023-03-09 | 9,375 | $7.12 | $66.8K | 0 | SEC↗ |
| Brewis Neil | CHIEF SCIENTIFIC OFFICER | U Tender | 2023-03-08 | 2023-03-09 | 105,088 | $7.12 | $748.2K | 9,375 | SEC↗ |
| Brady Todd C | Director | U Tender | 2023-03-08 | 2023-03-09 | 15,004 | $7.12 | $106.8K | 0 | SEC↗ |
| DEPTULA-HICKS DARLENE M | See Remarks | U Tender | 2023-03-08 | 2023-03-09 | 30,898 | $7.12 | $220.0K | 25,539 | SEC↗ |
| DEPTULA-HICKS DARLENE M | See Remarks | D To issuer | 2023-03-08 | 2023-03-09 | 25,539 | $7.12 | $181.8K | 0 | SEC↗ |
| Forster Eliot | PRESIDENT AND CEO | U Tender | 2023-03-08 | 2023-03-09 | 347,578 | $7.12 | $2.47M | 73,959 | SEC↗ |
| Forster Eliot | PRESIDENT AND CEO | D To issuer | 2023-03-08 | 2023-03-09 | 73,959 | $7.12 | $526.6K | 0 | SEC↗ |
| Kayitalire Louis | CHIEF MEDICAL OFFICER | D To issuer | 2023-03-08 | 2023-03-09 | 25,019 | $7.12 | $178.1K | 0 | SEC↗ |
| Kayitalire Louis | CHIEF MEDICAL OFFICER | U Tender | 2023-03-08 | 2023-03-09 | 29,236 | $7.12 | $208.2K | 25,019 | SEC↗ |
| Race Geoffrey | Director | M Exercise deriv | 2022-07-29 | 2023-01-09 | 3,937 | — | $0 | 3,937 | SEC↗ |
| Race Geoffrey | Director | M Exercise | 2022-07-29 | 2023-01-09 | 3,937 | $0.11 | $433 | 3,937 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | M Exercise deriv | 2022-07-29 | 2022-08-02 | 70,312 | — | $0 | 0 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | M Exercise deriv | 2022-07-29 | 2022-08-02 | 6,307 | — | $0 | 0 | SEC↗ |
| Forster Eliot | President and CEO | M Exercise deriv | 2022-07-29 | 2022-08-02 | 32,602 | — | $0 | 0 | SEC↗ |
| Forster Eliot | President and CEO | M Exercise deriv | 2022-07-29 | 2022-08-02 | 228,375 | — | $0 | 0 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | M Exercise | 2022-07-29 | 2022-08-02 | 76,619 | $0.11 | $8.4K | 114,463 | SEC↗ |
| Forster Eliot | President and CEO | M Exercise | 2022-07-29 | 2022-08-02 | 260,977 | $0.11 | $28.7K | 421,537 | SEC↗ |
| Arkowitz David | Director | A Award deriv | 2022-06-17 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Bermingham Nessan | Director | A Award deriv | 2022-06-17 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Klein Pamela M. | Director | A Award deriv | 2022-06-17 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Benz Edward JR | Director | A Award deriv | 2022-06-17 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Race Geoffrey | Director | A Award deriv | 2022-06-17 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Brady Todd C | Director | A Award deriv | 2022-06-17 | 2022-06-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | A Award deriv | 2022-03-31 | 2022-04-04 | 132,469 | — | $0 | 132,469 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | A Award deriv | 2022-03-31 | 2022-04-04 | 35,719 | — | $0 | 35,719 | SEC↗ |
| DEPTULA-HICKS DARLENE M | Treasurer and CFO | A Award deriv | 2022-03-31 | 2022-04-04 | 24,902 | — | $0 | 24,902 | SEC↗ |
| Forster Eliot | President and CEO | A Award deriv | 2022-03-31 | 2022-04-04 | 126,909 | — | $0 | 126,909 | SEC↗ |
| Forster Eliot | President and CEO | A Award deriv | 2022-01-09 | 2022-01-11 | 165,028 | — | $0 | 165,028 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | A Award deriv | 2022-01-09 | 2022-01-11 | 74,263 | — | $0 | 74,263 | SEC↗ |
| DEPTULA-HICKS DARLENE M | Treasurer and CFO | A Award deriv | 2022-01-09 | 2022-01-11 | 59,823 | — | $0 | 59,823 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | A Award deriv | 2022-01-09 | 2022-01-11 | 53,634 | — | $0 | 53,634 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | S Sale | 2021-11-02 | 2021-11-04 | 39 | $6.81 | $266 | 54,280 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | S Sale | 2021-11-02 | 2021-11-04 | 25 | $6.85 | $171 | 54,255 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | S Sale | 2021-10-04 | 2021-10-06 | 64 | $7.23 | $463 | 54,319 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | S Sale | 2021-07-02 | 2021-07-07 | 1,054 | $8.43 | $8.9K | 54,383 | SEC↗ |
| Arkowitz David | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Benz Edward JR | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Race Geoffrey | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Bermingham Nessan | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Brady Todd C | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Klein Pamela M. | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Krol Patrick Johan Hendrik | Director | A Award deriv | 2021-06-04 | 2021-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | A Award deriv | 2021-03-09 | 2021-03-11 | 12,880 | — | $0 | 40,169 | SEC↗ |
| DEPTULA-HICKS DARLENE M | Treasurer and CFO | A Award deriv | 2021-03-09 | 2021-03-11 | 25,894 | — | $0 | 54,320 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | A Award deriv | 2021-03-09 | 2021-03-11 | 22,561 | — | $0 | 99,180 | SEC↗ |
| Forster Eliot | President and CEO | A Award deriv | 2021-03-09 | 2021-03-11 | 127,924 | — | $0 | 388,901 | SEC↗ |
| DEPTULA-HICKS DARLENE M | Treasurer and CFO | A Award | 2021-02-01 | 2021-02-02 | 30,000 | — | $0 | 56,437 | SEC↗ |
| Benz Edward JR | Director | A Award | 2021-02-01 | 2021-02-02 | 4,385 | — | $0 | 4,385 | SEC↗ |
| Bermingham Nessan | Director | A Award | 2021-02-01 | 2021-02-02 | 87,000 | — | $0 | 103,875 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | A Award | 2021-02-01 | 2021-02-02 | 29,000 | — | $0 | 55,437 | SEC↗ |
| Forster Eliot | President and CEO | A Award | 2021-02-01 | 2021-02-02 | 142,000 | — | $0 | 160,560 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | A Award | 2021-02-01 | 2021-02-02 | 18,000 | — | $0 | 37,844 | SEC↗ |
| Arkowitz David | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 5,500 | — | $0 | 0 | SEC↗ |
| Arkowitz David | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 5,500 | — | $0 | 0 | SEC↗ |
| Arkowitz David | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 10,000 | — | $0 | 0 | SEC↗ |
| Arkowitz David | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 5,500 | — | $0 | 0 | SEC↗ |
| Arkowitz David | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 7,500 | — | $0 | 0 | SEC↗ |
| Arkowitz David | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 4,386 | — | $0 | 0 | SEC↗ |
| Arkowitz David | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 7,500 | — | $0 | 0 | SEC↗ |
| Brady Todd C | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 11,000 | — | $0 | 0 | SEC↗ |
| Brady Todd C | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 10,964 | — | $0 | 0 | SEC↗ |
| Brady Todd C | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 5,500 | — | $0 | 0 | SEC↗ |
| Brady Todd C | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 5,500 | — | $0 | 0 | SEC↗ |
| Brady Todd C | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 7,500 | — | $0 | 0 | SEC↗ |
| Brady Todd C | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 7,500 | — | $0 | 0 | SEC↗ |
| Klein Pamela M. | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 15,000 | — | $0 | 0 | SEC↗ |
| Klein Pamela M. | Director | J Other deriv | 2020-11-20 | 2023-03-09 | 7,500 | — | $0 | 0 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | A Award | 2020-11-20 | 2021-08-24 | 26,437 | — | $0 | 26,437 | SEC↗ |
| DEPTULA-HICKS DARLENE M | Treasurer and CFO | A Award | 2020-11-20 | 2021-08-24 | 26,437 | — | $0 | 26,437 | SEC↗ |
| Bermingham Nessan | Director | A Award | 2020-11-20 | 2021-08-24 | 16,875 | — | $0 | 16,875 | SEC↗ |
| Benz Edward JR | Director | A Award deriv | 2020-11-20 | 2020-11-24 | 3,937 | — | $0 | 3,937 | SEC↗ |
| Bermingham Nessan | Director | A Award deriv | 2020-11-20 | 2020-11-24 | 34,111 | — | $0 | 34,111 | SEC↗ |
| Bermingham Nessan | Director | A Award deriv | 2020-11-20 | 2020-11-24 | 16,875 | — | $0 | 16,875 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | A Award deriv | 2020-11-20 | 2020-11-24 | 6,307 | — | $0 | 6,307 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | A Award deriv | 2020-11-20 | 2020-11-24 | 70,312 | — | $0 | 70,312 | SEC↗ |
| DEPTULA-HICKS DARLENE M | Treasurer and CFO | A Award deriv | 2020-11-20 | 2020-11-24 | 26,437 | — | $0 | 26,437 | SEC↗ |
| DEPTULA-HICKS DARLENE M | Treasurer and CFO | A Award deriv | 2020-11-20 | 2020-11-24 | 28,426 | — | $0 | 28,426 | SEC↗ |
| Forster Eliot | President and CEO | A Award deriv | 2020-11-20 | 2020-11-24 | 228,375 | — | $0 | 228,375 | SEC↗ |
| Forster Eliot | President and CEO | A Award deriv | 2020-11-20 | 2020-11-24 | 32,602 | — | $0 | 32,602 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | A Award deriv | 2020-11-20 | 2020-11-24 | 26,437 | — | $0 | 26,437 | SEC↗ |
| Kayitalire Louis | Chief Medical Officer | A Award deriv | 2020-11-20 | 2020-11-24 | 27,289 | — | $0 | 27,289 | SEC↗ |
| Race Geoffrey | Director | A Award deriv | 2020-11-20 | 2020-11-24 | 3,937 | — | $0 | 3,937 | SEC↗ |
| Brewis Neil | Chief Scientific Officer | A Award | 2020-11-20 | 2020-11-24 | 19,844 | — | $0 | 19,844 | SEC↗ |
| Forster Eliot | President and CEO | A Award | 2020-11-20 | 2020-11-24 | 18,560 | — | $0 | 18,560 | SEC↗ |